Leukaemic transformation with romiplostim.
Department of Haematology, Eastbourne District General Hospital, Eastbourne, East Sussex, UK.
Kate
K
Gardner
Department of Histopathology, Eastbourne District General Hospital, Eastbourne, East Sussex, UK.
Stanford
S
Mathe
Department of Haematology, Eastbourne District General Hospital, Eastbourne, East Sussex, UK.
Satyajit
S
Sahu
D000369:Aged, 80 and over; D002471:Cell Transformation, Neoplastic / Q000187:drug effects*; D003937:Diagnosis, Differential; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced* / Q000473:pathology; D017254:Leukemic Infiltration / Q000139:chemically induced / Q000473:pathology; D009190:Myelodysplastic Syndromes / Q000175:diagnosis / Q000188:drug therapy; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000175:diagnosis; D011961:Receptors, Fc; D053628:Receptors, Thrombopoietin / Q000819:agonists; D011993:Recombinant Fusion Proteins / Q000009:adverse effects*; D012867:Skin / Q000473:pathology; D013926:Thrombopoietin / Q000009:adverse effects*
D011961:Receptors, Fc; D053628:Receptors, Thrombopoietin; D011993:Recombinant Fusion Proteins; D013926:Thrombopoietin; C488777:romiplostim